Amylin Speculation Intensifies, Part 2: Activist Shareholders Grow Restless
This article was originally published in The Pink Sheet Daily
Executive Summary
Eastbourne Capital says it wants Amylin to find a buyer. Is Lilly ready for another billion dollar deal?